Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Intranasal Dexmedetomidine and Fentanyl Versus Intravenous Midazolam and Ketamine in Sedation for Painful Outpatient Procedures


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04621110

Organisation Name: University of Sao Paulo General Hospital

Overal Status: Not yet recruiting

Start Date: June 1, 2021

Last Update: April 1, 2021

Lead Sponsor: University of Sao Paulo General Hospital

Brief Summary: Pain is a vital sign that depends on personal experience involving different factors such as previous sensory and emotional experience, age, spiritual and cultural aspects, that makes it harder to evaluate, especially in young children. Pain control is important to diminish the anxiety of the child and family, also this is more important in patients who require procedure and treatment that are more painful, like oncological and hematological patients. The study aims to measure if the intranasal drugs (dexmedetomidine and fentanyl) has the same outcomes when compared with intravenous drug (ketamine and midazolam), but with less side effects. The participants are patients from an oncologic outpatient, that will be submitted to cerebrospinal fluid puncture, myelogram or both will be randomized assigned to both groups. The study will compare physiological variables ( heart rate, respiratory rate and blood pressure) and sedation and pain scales to see if its work properly. The study purpose is to evaluate if intranasal drug works in the same way with less side effects comparing with the usual treatment.

Conditions:
  • Pediatric Cancer
  • Analgesia
  • Procedural Pain


Total execution time in seconds: 0.16845512390137